Enanta Pharmaceuticals
ENTA
ENTA
126 hedge funds and large institutions have $396M invested in Enanta Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 46 increasing their positions, 48 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
50% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 32
77% less call options, than puts
Call options by funds: $412K | Put options by funds: $1.79M
Holders
126
Holding in Top 10
2
Calls
$412K
Puts
$1.79M
Top Buyers
| 1 | +$70.4M | |
| 2 | +$12.1M | |
| 3 | +$10.7M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$9.24M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$7.18M |
Top Sellers
| 1 | -$27.7M | |
| 2 | -$9.44M | |
| 3 | -$9.2M | |
| 4 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$6.71M |
| 5 |
SCP
Seizert Capital Partners
Birmingham,
Michigan
|
-$5.11M |